Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +36.87%
#3 Nockchain Nockchain +25.37%
#4 Fabric Protocol Fabric Protocol +22.82%
#5 Bedrock Bedrock +16.06%
#6 Cysic Cysic +13.33%
#7 Perle Perle +12.38%
#8 Arowana Arowana +8.55%
#9 Theta Network Theta Network +7.05%
#10 Anvil Anvil +6.18%
Coin of the day
EXOD EXOD
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Idogen AB (publ) Idogen AB (publ)

Idogen AB (publ)

IDOGEN
Classement en actions #37811
Idogen AB (publ) is a Swedish biotechnology company specializing in the... Idogen AB (publ) is a Swedish biotechnology company specializing in the development of tolerogenic cell therapies. These innovative treatments are engineered to prevent a patient's immune system from attacking crucial elements, including biological agents, transplanted organs, and the body's own cells or tissues. The company's most advanced product in development is IDO 8, designed for individuals with severe haemophilia A who have developed neutralizing antibodies against their vital coagulation factor VIII treatment. Idogen is also developing IDO T, a tolerogenic cell therapy intended to prevent organ transplant rejection, primarily for kidney transplants, and IDO AID, aimed at treating autoimmune diseases. Established in 2008, the company is headquartered in Lund, Sweden.
Prix de l'action
$0.01345907
Dernière synchronisation: 2024-07-12
Capitalisation boursière
$1.43M
Changement (1 jour)
22.16%
Changement (1 an)
0.00%
Pays
SE
Échange Idogen AB (publ) (IDOGEN)

Catégorie

Healthcare
Historique du prix de l'action pour Idogen AB (publ) (IDOGEN)
Prix de clôture le plus élevé : $0.01 le 2024-07-01

Prix de clôture le plus bas : $6.87 le 2015-06-01
Historique du prix de l'action de Idogen AB (publ) de 2015 à 2026
Performance annuelle du prix de l'action
Année Performance
2024 17.75%
2023 -33.56%
2022 -90.58%
2021 -53.76%
2020 -45.68%
2019 -53.15%
2018 -66.56%
2017 -52.66%
2016 54.52%
2015 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE